Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vancomycin pharmacokinetics in middle-aged and elderly men

A E Leonard1, M S Boro

  • 1Pharmacy Corporation of America, Union City, CA.

American Journal of Hospital Pharmacy
|March 15, 1994
PubMed
Summary

This study refined vancomycin clearance (CL) values for better serum vancomycin concentration (SVC) predictions in older men. A CL of 0.90 times creatinine clearance (CLcr) proved more accurate than the standard 0.65 CLcr.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibitory effect of conjugated linoleic acid on linoleic acid elongation in transformed yeast with human elongase.

Lipids·2002
Same author

Expression of fungal desaturase genes in cultured mammalian cells.

Molecular and cellular biochemistry·2001
Same author

Polyunsaturated fatty acid-specific elongation enzymes.

Biochemical Society transactions·2001
Same author

Cloning of a human cDNA encoding a novel enzyme involved in the elongation of long-chain polyunsaturated fatty acids.

The Biochemical journal·2000
Same author

Genetic and epigenetic mechanisms contribute to motor neuron pathfinding.

Nature·2000
Same author

Identification and characterization of an enzyme involved in the elongation of n-6 and n-3 polyunsaturated fatty acids.

Proceedings of the National Academy of Sciences of the United States of America·2000

Area of Science:

  • Pharmacokinetics
  • Clinical Pharmacy
  • Drug Monitoring

Background:

  • Accurate prediction of serum vancomycin concentrations (SVCs) is crucial for effective treatment.
  • Existing pharmacokinetic parameters for vancomycin may require refinement for specific patient populations.
  • Bayesian analysis offers a method for updating pharmacokinetic values based on observed data.

Purpose of the Study:

  • To establish new vancomycin volume of distribution (V) and clearance (CL) values for improved SVC prediction.
  • To compare the predictive performance of newly derived CL values against established population values.
  • To evaluate the accuracy of vancomycin CL estimation in middle-aged and elderly men.

Main Methods:

  • Retrospective analysis of vancomycin use in a Veterans Affairs medical center.
  • Division of patients into two groups based on SVC measurement dates for data derivation and validation.
  • Bayesian analysis used to derive new pharmacokinetic parameters from group 1 data.
  • Comparison of predicted SVCs using new and conventional CL values (0.65 CLcr vs. 0.90 CLcr) in group 2.

Main Results:

  • The volume of distribution (V) could not be reliably evaluated due to sample size limitations.
  • A vancomycin clearance (CL) value of 0.90 times creatinine clearance (CLcr) demonstrated greater precision and less bias in estimating SVCs compared to the conventional 0.65 CLcr.
  • This improved accuracy was observed specifically in middle-aged and elderly male patients.

Conclusions:

  • A vancomycin CL of 0.90 CLcr is a more precise and less biased predictor of SVCs in middle-aged and elderly men than the conventional 0.65 CLcr.
  • Refined pharmacokinetic parameters, particularly for CL, can enhance therapeutic drug monitoring of vancomycin.
  • Further studies may be needed to establish reliable V values and validate these findings in diverse populations.

Related Experiment Videos